McKesson logo

McKesson(MCK)

Leader

Largest US pharmaceutical distributor with $308.9B FY2024 revenue; thin-margin distribution triopoly with Cencora and Cardinal Health; US Oncology Network (1,700+ oncologists) is highest-margin segment.

79
AI Score
Grade B
AI Visibility Score (Beta)
HealthcareMCKWebsiteUpdated October 2026

Brand Intelligence Graphcompany

Company Overview

About McKesson

McKesson Corporation is the largest pharmaceutical distributor in North America and a leading healthcare services company, founded in 1833 in New York City by John McKesson and Charles Olcott and now headquartered in Irving, Texas, trading on NYSE (MCK). The company reported approximately $308.9 billion in revenues for fiscal year 2024 (ending March 31, 2024) under CEO Brian Tyler, making it one of the highest-revenue companies in the United States—though the vast majority of revenues represent pass-through pharmaceutical product costs distributed to approximately 40,000 pharmacies, health systems, and medical providers across North America. McKesson operates through four segments: U.S. Pharmaceutical (the dominant distribution engine), Prescription Technology Solutions (pharmacy benefits technology including CoverMyMeds e-prior authorization), Medical-Surgical Solutions (physician office and extended care medical supply distribution), and International (primarily Canadian distribution through McKesson Canada).

Business Model & Competitive Advantage

McKesson's pharmaceutical distribution business generates thin but highly predictable gross margins—typically 2-4% of revenues—on the enormous volume of branded and generic pharmaceuticals flowing from manufacturers to dispensing points. The company earns fee-for-service and price appreciation income in addition to distribution margin, particularly from branded pharmaceuticals where manufacturer price increases translate into inventory holding gains. The specialty pharmaceutical distribution segment—particularly oncology drugs distributed through McKesson's US Oncology Network (a physician services organization supporting over 1,700 oncologists)—commands higher margins than standard pharmaceutical distribution and provides access to high-cost specialty drugs that require specialized handling, reimbursement support, and clinical expertise.

Competitive Landscape 2025–2026

In 2025-2026, McKesson competes with Cencora (formerly AmerisourceBergen, ABC) and Cardinal Health (CAH) in the pharmaceutical distribution triopoly that collectively handles approximately 90% of U.S. pharmaceutical distribution. This oligopolistic structure provides pricing stability and durable margins absent competitive disruption. The three distributors' partial responsibility (as wholesalers) for the U.S. opioid epidemic resulted in a combined $21 billion settlement in 2022—McKesson's share approximately $8.2 billion payable over 18 years—creating a significant financial obligation that is being funded from ongoing free cash flow. McKesson's increasing focus on oncology—through US Oncology Network expansion, specialty drug distribution growth, and oncology software platforms—addresses the highest-growth and highest-margin segment within pharmaceutical distribution.

Founded
1833
Headquarters
Manhattan, New York
Revenue
$308.9B
Curated content • Fact-checked and verified

The McKesson Story

Founded in 1833
Manhattan, New York
Founded by John McKesson, Charles Olcott

Founders

John McKessonCharles Olcott

Recent Activity

View all →

Company Timeline

Major milestones in McKesson's journey

16
Total Events
7
Acquisitions
1
Product Launches

Leadership Team

Meet the leaders behind McKesson

Brian S. Tyler, Ph.D.

Chief Executive Officer & Board Member

Brian Tyler has served as CEO of McKesson Corporation since April 2019 and previously served as President and Chief Operating Officer from August 2018 to March 2019. With more than 25 years at McKesson, Tyler has held wide-ranging leadership roles across McKesson Europe, North American Pharmaceutical Distribution Services, Corporate Strategy and Business Development, and other divisions, bringing comprehensive company knowledge and strategic vision to the CEO role.

Leann Smith

Executive Vice President & Chief Human Resources Officer

Leann Smith leads McKesson's global human resources strategy, overseeing talent acquisition, employee development, compensation and benefits, diversity and inclusion initiatives, and organizational culture across the company's 80,000+ employee base spanning North America and international operations.

Tom Rodgers

Executive Vice President & Chief Strategy and Business Development Officer

Tom Rodgers is responsible for McKesson's corporate strategy development, mergers and acquisitions execution, strategic partnerships, and long-term business planning. He has played a key role in major strategic transactions including the Core Ventures, PRISM Vision Holdings, and Compile acquisitions that have strengthened McKesson's specialty healthcare platform.

Dr. Kelvin Baggett

Chief Impact Officer

Dr. Kelvin Baggett leads McKesson's global strategy and execution of environmental, social, and governance (ESG) positions, sustainability and environmental practices, diversity, equity and inclusion (DEI) initiatives, McKesson Foundation philanthropy, and corporate social responsibility programs, positioning the company as a responsible corporate citizen.

Key Differentiators

Market Leader

McKesson is recognized as a market leader in the Healthcare sector, demonstrating strong industry presence and customer trust.

Enterprise Scale

With $308.9B in revenue, McKesson operates at enterprise scale with proven market validation.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

79
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Pfizer logo

Pfizer

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan

Moderna logo

Moderna

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép

Amgen logo

Amgen

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

Epic Systems logo

Epic Systems

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el

athenahealth logo

athenahealth

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on

Compare McKesson with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For McKesson

Claim This Profile

Are you from McKesson? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim McKesson Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention McKesson vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →